THC (tetrahydrocannabinol)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for THC (tetrahydrocannabinol), covering 2025-08-12 to 2025-08-12. Get the full timeline:
Most recent: Clinical Trial Update: Use of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alzheimer's Disease and Cannabis Clinical Trial (DAZACANN) Open-Label Phase [Phase 1, Phase 2]